Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Apollomics, Inc. Apollomics Co-Founder and President, Sanjeev Redkar, Ph.D., to Speak at 23rd Annual R. Bryan Miller Symposium April 11, 2023 From Apollomics, Inc. Via GlobeNewswire Tickers APLM APLMW Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq March 30, 2023 From Apollomics, Inc. Via GlobeNewswire Tickers JMAC Apollomics Announces Completion of Business Combination and Listing on Nasdaq March 29, 2023 From Apollomics, Inc. Via ACN Newswire Tickers JMAC JMACU Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations November 15, 2022 From Apollomics, Inc. Via GlobeNewswire Tickers JMAC JMACU JMACW Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer July 26, 2022 From Apollomics, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
